Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Schulz

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Ecology and Evolution|August 6, 2019
Parthenogenetic <i>vs</i>. sexual reproduction in oribatid mite communitiesMark Maraun, Tancredi Caruso, Jonathan Hense, et al.
Blood Cancer Journal|April 30, 2021
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantationMadlen Jentzsch, Juliane Grimm, Marius Bill, et al.
Schizophrenia Bulletin|August 22, 2023
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia SpectrumJulia Schulz, Felix Brandl, Michel J Grothe, et al.
Blood Advances|May 23, 2022
Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remissionMadlen Jentzsch, Lara Bischof, Donata Backhaus, et al.
American Journal of Hematology|April 3, 2021
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantationMadlen Jentzsch, Juliane Grimm, Marius Bill, et al.
Frontiers in Psychiatry|November 29, 2023
Lower cortical thickness and increased brain aging in adults with cocaine use disorderDavid Schinz, Benita Schmitz-Koep, Marlene Tahedl, et al.
Cancers|November 27, 2021
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell TransplantationDonata Backhaus, Madlen Jentzsch, Lara Bischof, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 26, 2017
Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunctionFabio Ius, Julia Schulz, Mazen Roumieh, et al.
Schizophrenia Bulletin|April 5, 2024
Distinct Volume Alterations of Thalamic Nuclei Across the Schizophrenia SpectrumMelissa Thalhammer, Julia Schulz, Felicitas Scheulen, et al.
American Journal of Hematology|July 21, 2021
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantationJuliane Grimm, Madlen Jentzsch, Marius Bill, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Ecology and Evolution|August 6, 2019
Parthenogenetic <i>vs</i>. sexual reproduction in oribatid mite communitiesMark Maraun, Tancredi Caruso, Jonathan Hense, et al.
Blood Cancer Journal|April 30, 2021
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantationMadlen Jentzsch, Juliane Grimm, Marius Bill, et al.
Schizophrenia Bulletin|August 22, 2023
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia SpectrumJulia Schulz, Felix Brandl, Michel J Grothe, et al.
Blood Advances|May 23, 2022
Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remissionMadlen Jentzsch, Lara Bischof, Donata Backhaus, et al.
American Journal of Hematology|April 3, 2021
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantationMadlen Jentzsch, Juliane Grimm, Marius Bill, et al.
Frontiers in Psychiatry|November 29, 2023
Lower cortical thickness and increased brain aging in adults with cocaine use disorderDavid Schinz, Benita Schmitz-Koep, Marlene Tahedl, et al.
Cancers|November 27, 2021
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell TransplantationDonata Backhaus, Madlen Jentzsch, Lara Bischof, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 26, 2017
Long-term results of the Mitroflow aortic pericardial bioprosthesis in over 800 patients: limited durability and mechanisms of dysfunctionFabio Ius, Julia Schulz, Mazen Roumieh, et al.
Schizophrenia Bulletin|April 5, 2024
Distinct Volume Alterations of Thalamic Nuclei Across the Schizophrenia SpectrumMelissa Thalhammer, Julia Schulz, Felicitas Scheulen, et al.
American Journal of Hematology|July 21, 2021
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantationJuliane Grimm, Madlen Jentzsch, Marius Bill, et al.
Pageof 4